PT91197A - Processo para a preparacao de composicoes farmaceuticas contendo 3,4-dihidro- -2h-benzopiranos substituidos apropriados para o tratamento de perturbacoes funcionais obstrutivas do pulmao e/ou perturbacoes das vias urinarias descendentes - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo 3,4-dihidro- -2h-benzopiranos substituidos apropriados para o tratamento de perturbacoes funcionais obstrutivas do pulmao e/ou perturbacoes das vias urinarias descendentes

Info

Publication number
PT91197A
PT91197A PT91197A PT9119789A PT91197A PT 91197 A PT91197 A PT 91197A PT 91197 A PT91197 A PT 91197A PT 9119789 A PT9119789 A PT 9119789A PT 91197 A PT91197 A PT 91197A
Authority
PT
Portugal
Prior art keywords
alkyl
dihydro
pulmao
perturbactions
benzopyranes
Prior art date
Application number
PT91197A
Other languages
English (en)
Other versions
PT91197B (pt
Inventor
Bernward Scholkens
Heinrich Christian Englert
Dieter Mania
Erik Klaus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT91197A publication Critical patent/PT91197A/pt
Publication of PT91197B publication Critical patent/PT91197B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrane Compounds (AREA)
PT91197A 1988-07-19 1989-07-18 Processo para a preparacao de composicoes farmaceuticas contendo 3,4-dihidro- -2h-benzopiranos substituidos apropriados para o tratamento de perturbacoes funcionais obstrutivas do pulmao e/ou perturbacoes das vias urinarias descendentes PT91197B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3824446A DE3824446A1 (de) 1988-07-19 1988-07-19 Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege

Publications (2)

Publication Number Publication Date
PT91197A true PT91197A (pt) 1990-02-08
PT91197B PT91197B (pt) 1995-07-18

Family

ID=6359009

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91197A PT91197B (pt) 1988-07-19 1989-07-18 Processo para a preparacao de composicoes farmaceuticas contendo 3,4-dihidro- -2h-benzopiranos substituidos apropriados para o tratamento de perturbacoes funcionais obstrutivas do pulmao e/ou perturbacoes das vias urinarias descendentes

Country Status (18)

Country Link
EP (2) EP0351720B1 (pt)
JP (1) JPH0273015A (pt)
KR (1) KR900001367A (pt)
AT (1) ATE110270T1 (pt)
AU (1) AU621388B2 (pt)
CA (1) CA1336891C (pt)
CZ (1) CZ417091A3 (pt)
DE (2) DE3824446A1 (pt)
DK (1) DK171782B1 (pt)
ES (1) ES2061816T3 (pt)
FI (1) FI893460A (pt)
HU (1) HU210149B (pt)
IE (1) IE63872B1 (pt)
IL (1) IL91015A (pt)
NZ (1) NZ229961A (pt)
PH (1) PH26696A (pt)
PT (1) PT91197B (pt)
ZA (1) ZA895459B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW244350B (pt) * 1991-12-14 1995-04-01 Hoechst Ag
TW316850B (pt) * 1992-02-28 1997-10-01 Takeda Pharm Industry Co Ltd
HUT72741A (en) * 1992-12-19 1996-05-28 Alkaloida Vegyeszeti Gyar Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US7029656B2 (en) 1999-12-23 2006-04-18 Coifman Robert E Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
KR100475147B1 (ko) * 2002-09-09 2005-03-10 정의상 알루미나 분진 중의 유해가스 제거를 위한 탈취제 조성물
US7306789B2 (en) 2002-11-12 2007-12-11 Warner-Lambert Company, Llc Method of stimulating hair growth using benzopyrans

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
DE3881714D1 (de) * 1987-02-04 1993-07-22 Hoechst Ag Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Also Published As

Publication number Publication date
EP0351720B1 (de) 1994-08-24
HU210149B (en) 1995-02-28
EP0351720A3 (de) 1992-01-02
NZ229961A (en) 1991-11-26
IE892323L (en) 1990-01-19
AU3818989A (en) 1990-01-25
DE3824446A1 (de) 1990-01-25
KR900001367A (ko) 1990-02-27
CZ417091A3 (en) 1993-02-17
ZA895459B (en) 1990-03-28
CA1336891C (en) 1995-09-05
FI893460A (fi) 1990-01-20
PH26696A (en) 1992-09-15
IE63872B1 (en) 1995-06-14
EP0560399A1 (de) 1993-09-15
DK171782B1 (da) 1997-05-26
DK355489A (da) 1990-01-20
ES2061816T3 (es) 1994-12-16
PT91197B (pt) 1995-07-18
JPH0273015A (ja) 1990-03-13
EP0351720A2 (de) 1990-01-24
FI893460A0 (fi) 1989-07-17
ATE110270T1 (de) 1994-09-15
HUT55988A (en) 1991-07-29
AU621388B2 (en) 1992-03-12
IL91015A (en) 1994-11-28
DE58908228D1 (de) 1994-09-29
DK355489D0 (da) 1989-07-18

Similar Documents

Publication Publication Date Title
FI941378A (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
AU1326088A (en) Heterocyclic dihydroquinoxaline compounds and their preparation and use
BR0215151A (pt) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
PT91197A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 3,4-dihidro- -2h-benzopiranos substituidos apropriados para o tratamento de perturbacoes funcionais obstrutivas do pulmao e/ou perturbacoes das vias urinarias descendentes
ES2112874T3 (es) Utilizacion de acidos carboxilicos con contenido en azufre para combatir trastornos de excitacion de origen patofisiologico.
DK408987A (da) Phenoxyeddikesyrederivater samt fremstilling deraf
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
IE880294L (en) Substituted 3,4-dihydro-2h-benzopyrans, process for their¹preparation, their use and pharmaceutical products based on¹these compounds
YU21391A (sh) Triciklični-ciklični amini kao novi inhibitori holinesteraze
SE8500996D0 (sv) Method of treatment
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
IE880295L (en) Alkyl-substitued n-benzopyranyllactams
TR26593A (tr) HIDROFIL DURUM GETIRILMIS TRIGLISERID'LERIN üRETILMESINE MAHSUS USUL.
MX9302889A (es) Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos.
HUP9901247A2 (hu) Naftimidazol-, naftoxazol- és naftotiazol-dion-származékok alkalmazása érrendszeri elváltozások okozta betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, valamint új származékok
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ATE161844T1 (de) Acyl-(2'-hydroxybiphenyl-2-yl)- phosphinsäuresalze, ihre herstellung und verwendung
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
PT90302A (pt) Processo para a preparacao de derivados de lactamas hetero-tetraciclicas
KR870006043A (ko) 피라진유도체 그 제조방법 및 약제조성물
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
AR030879A1 (es) Uso de derivados del acido hidroperoxieicosatetraenoico luego de cirugia refractiva
PT1264836E (pt) Processos para a preparacao de derivados de indolopirrolocarbazole
PT97885A (pt) Processo para a preparacao de derivados da {(1-aril-2-pirrolidinil)-metil-piperazina e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20030930